Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ME

Should You Scoop Up Shares of 23andMe?

23andMe (ME) saw its shares slump in price after it reported its fourth-quarter earnings results last month. However, given the company's multiple FDA authorizations for over-the-counter genetic health risk reports, would it be worth scooping up its shares now? Read on, let's find out.

Dwayne Haskins ‘drank heavily’ at club before he was killed by dump truck in South Florida

Dwayne Haskins, the NFL quarterback hit and killed while walking on a South Florida highway, had been out at a club drinking “heavily” and had a significant amount of alcohol in his blood, according to medical examiner reports released on Monday.

GF Tomlinson finishes work on nuclear physics bunker ‘built with safety and security of the utmost priority’

GF Tomlinson finishes work on nuclear physics bunker ‘built with safety and security of the utmost priority’

It will allow researchers to understand how neutrons interact, which will be applied to nuclear medicine and space

Birmingham Post

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

A civil suit reveals new details in the case of a Philly woman whose death by 20 stab wounds was ruled suicide

PHILADELPHIA — A nor'easter was blanketing Philadelphia with snow when Samuel Goldberg's call came in to the city's 911 center at 6:30 p.m. on Jan. 26, 2011.

The Philadelphia Inquirer

3 Healthtech Stocks Wall Street Predicts Will Rally More Than 40% or More: GoodRx, 23andMe, and Exact Sciences

The COVID-19 pandemic has accelerated digital adoption in healthcare. And because this trend is attracting massive investments into digital health care, Wall Street analysts expect popular health tech stocks Exact Sciences Corp (EXAS), GoodRx Holdings (GDRX), 23andMe (ME) to rally in price soon. Read on.

Morbius: Jared Leto says cinemas might no longer exist without Marvel films

The star, who is set to play Morbius in a new comic book film, seemed to credit Marvel with keeping movie theatres open in a new interview

Evening Standard

Albert Labs, Psychedelic Biotech Company Shares Now Available On Canadian Exchange

Albert Labs, a British-Columbia based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.”

inkl

Read news from The Economist, FT, and more,
with one subscription

Pandora launch four-leaf clover charm for under £20 for St Patrick's Day

Pandora launch four-leaf clover charm for under £20 for St Patrick's Day

The lucky charm is the perfect gift for someone celebrating the Irish holiday on March 17

Manchester Evening News

This Colorful McLaren Puts Art In The Artura Hybrid Supercar

This Colorful McLaren Puts Art In The Artura Hybrid Supercar

It will be displayed at the ME Dubai hotel until March 31, 2021.

23andMe's Q3 Topline Beat Estimates On Boost From Telehealth Business Acquisition

23andMe's Q3 Topline Beat Estimates On Boost From Telehealth Business Acquisition

23andMe Holding Co (NASDAQ: ME) has updated its FY22 guidance following the inclusion of telehealth operations into its consumer business.

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

Here's a roundup of top developments in the biotech space over the last 24 hours:

Why Jim Cramer Like NextEra Energy And Lincoln Electric?

Why Jim Cramer Like NextEra Energy And Lincoln Electric?

On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE: NEE) is the "fastest growing utility." He recommended buying the stock today morning.

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?

23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?

Genetic testing company 23andMe Holding Co.

People

Michael Morbius

Ellen Greenberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

University of Birmingham

Canadian Securities Exchange

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

249,077 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play